
1. General Information
Lenalid 10 mg Capsule contains lenalidomide 10 mg, an immunomodulatory medicine used in the management of certain blood cancers and related disorders. Lenalidomide is a thalidomide analogue and is generally prescribed under the supervision of a specialist physician. It is available as an oral capsule and is a prescription-only medicine.
Phoenix Exim, based in Nagpur, India, is engaged in the supply and export of pharmaceutical products to international markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable import regulations and prescription requirements.
Important: Lenalidomide is a high-risk prescription medicine. It can cause serious birth defects, low blood-cell counts, and blood clots, so treatment requires appropriate medical supervision and monitoring.
2. Product Information
- Product name: Lenalid 10 mg Capsule
- Active ingredient: Lenalidomide
- Strength: 10 mg
- Dosage form: Oral capsule
- Therapeutic class: Immunomodulatory agent / antineoplastic medicine
- Route of administration: Oral
- Prescription status: Prescription medicine
- Manufacturer: Product-specific manufacturer should be verified from the actual pack and batch documentation.
Lenalidomide is used for specific indications including multiple myeloma, certain myelodysplastic syndromes, and selected lymphomas depending on the patient's clinical condition and local approved labeling.
3. Uses of Lenalid 10 mg Capsule
Under specialist medical supervision, lenalidomide may be used for:
- Multiple myeloma, commonly in combination with dexamethasone.
- Maintenance treatment of multiple myeloma following autologous hematopoietic stem-cell transplantation.
- Certain myelodysplastic syndromes (MDS) associated with deletion 5q and transfusion-dependent anemia.
- Mantle cell lymphoma in selected patients whose disease has relapsed or progressed following previous therapies.
- Certain previously treated follicular lymphoma and marginal zone lymphoma, in combination with rituximab products where approved.
The exact indication depends on the patient's diagnosis, previous treatment, laboratory results, and the prescribing country's approved labeling.
4. Benefits of This Medicine
When appropriately prescribed, lenalidomide can provide several therapeutic benefits:
- Helps control abnormal plasma cells in multiple myeloma.
- Can help reduce or control disease activity in selected blood cancers.
- May be used as maintenance therapy after stem-cell transplantation in multiple myeloma.
- Can improve transfusion-dependent anemia in certain patients with deletion-5q MDS.
- Provides an established oral treatment option for selected hematological malignancies.
The benefits vary according to the underlying disease and the patient's response to treatment.
5. Side Effects of Lenalid 10 mg Capsule
Lenalidomide can cause side effects ranging from mild to serious. Important adverse effects include:
- Low white blood-cell count (neutropenia)
- Low platelet count (thrombocytopenia)
- Anemia
- Increased risk of blood clots
- Diarrhea or constipation
- Fatigue and weakness
- Nausea
- Skin rash
- Fever
- Shortness of breath
- Dizziness
- Peripheral swelling
- Increased susceptibility to infections
Serious complications can include venous or arterial thromboembolism, severe reduction in blood-cell counts, serious allergic reactions, and embryo-fetal toxicity.
6. Common Side Effects
Depending on the condition being treated, commonly reported adverse reactions include:
- Diarrhea
- Constipation
- Fatigue
- Nausea
- Anemia
- Neutropenia
- Thrombocytopenia
- Leukopenia
- Rash
- Cough or upper respiratory infection
- Muscle cramps
- Headache
- Dizziness
- Fever
- Decreased appetite
- Shortness of breath
- Peripheral edema
Not every patient experiences these effects, and their severity can vary.
7. How to Use Lenalid 10 mg Capsule
Lenalid 10 mg should be taken only according to the oncologist's prescription. The dose and treatment schedule depend on the indication, kidney function, blood counts, other medicines, and the patient's response.
General administration guidance includes:
- Take the capsule exactly as prescribed.
- It may generally be taken with or without food.
- Swallow the capsule whole with water.
- Do not crush, chew, or open the capsule.
- Take it at approximately the same time on scheduled treatment days.
- Do not change the dose or treatment schedule without medical advice.
- If a dose is missed, follow the instructions provided by the treating physician or product information.
Dose adjustments may be necessary in patients with renal impairment or significant treatment-related toxicity.
8. How This Medicine Works
Lenalidomide is an immunomodulatory and anticancer medicine. It affects immune-system activity and influences cellular pathways involved in the growth and survival of abnormal blood cells.
In multiple myeloma and other eligible conditions, these effects can help inhibit abnormal cell growth and support the body's immune response against malignant cells. The exact mechanism is complex and varies between disease settings.
9. Safety Advice for This Medicine
Pregnancy: Lenalidomide can cause severe, life-threatening birth defects or fetal death. It must not be used during pregnancy. Appropriate pregnancy-prevention requirements and testing apply to patients who could become pregnant.
Breastfeeding: Breastfeeding is not recommended during treatment.
Blood counts: Regular blood tests are required because lenalidomide can significantly reduce neutrophils, platelets, and other blood cells.
Blood clots: Lenalidomide, particularly when used with dexamethasone in multiple myeloma, can increase the risk of DVT, pulmonary embolism, heart attack, and stroke. Your physician may prescribe thrombosis-prevention treatment when appropriate.
Kidney problems: Dose adjustment may be required in patients with impaired kidney function.
Allergy: Seek urgent medical attention for facial or throat swelling, difficulty breathing, or other signs of a serious allergic reaction.
Drug interactions: Tell your doctor about all medicines and supplements you take. Certain medicines and estrogen-containing therapies may affect clotting risk, while digoxin levels may require monitoring.
Medical supervision: Treatment should be initiated and monitored by a physician experienced in managing hematological malignancies.
10. Frequently Asked Questions (FAQs)
Q1. What is Lenalid 10 mg Capsule?
Lenalid 10 mg contains lenalidomide 10 mg and is an oral prescription medicine used for certain blood cancers and related disorders.
Q2. What is Lenalid 10 mg used for?
It may be prescribed for multiple myeloma, certain deletion-5q myelodysplastic syndromes, and selected lymphoma indications depending on the approved labeling and clinical circumstances.
Q3. Is Lenalid 10 mg a chemotherapy medicine?
It is an anticancer medicine but belongs specifically to the immunomodulatory drug (IMiD) class rather than conventional cytotoxic chemotherapy.
Q4. Can Lenalid 10 mg be taken without a prescription?
No. It requires specialist medical supervision because it can cause serious blood, clotting, and pregnancy-related risks.
Q5. Can pregnant women take lenalidomide?
No. Lenalidomide can cause severe fetal harm and must not be used during pregnancy. Strict pregnancy-prevention requirements apply.
Q6. Does Lenalid 10 mg require blood tests?
Yes. Doctors commonly monitor blood counts and other laboratory parameters during treatment because significant neutropenia and thrombocytopenia can occur.
Q7. Can the dose of lenalidomide be changed?
Yes, but only by the treating physician. Dose modifications may be necessary depending on kidney function, blood counts, and adverse reactions.
Q8. Is Lenalid 10 mg the same as lenalidomide 10 mg?
Lenalid 10 is a brand product containing lenalidomide 10 mg. Equivalent products should be verified by active ingredient, strength, manufacturer, and regulatory approval.
11. Substitutes for Lenalid 10 mg
Possible alternatives or equivalent lenalidomide 10 mg brands may vary by country and availability. Examples of lenalidomide products include:
- Revlimid 10 mg – lenalidomide
- Lenalid 10 mg – lenalidomide
- Other locally approved lenalidomide 10 mg generic or branded products
A substitute should not be selected solely on brand name. The prescribing physician or pharmacist should confirm the active ingredient, strength, indication, manufacturer, regulatory status, and appropriate dosing.
12. SEO / B2B Keywords
- Lenalid 10 mg Capsule exporter from India
- Lenalidomide 10 mg Capsule supplier India
- Lenalid 10 mg pharmaceutical exporter
- Lenalidomide 10 mg medicine exporter from Nagpur
- Buy Lenalid 10 mg for authorized medical supply
- Lenalid 10 mg wholesale pharmaceutical supplier
- Lenalidomide 10 mg B2B supplier India
- Lenalid 10 mg international medicine supplier
- Lenalidomide 10 mg exporter to USA
- Lenalid 10 mg exporter to UK
- Lenalidomide 10 mg exporter to Australia
- Lenalid 10 mg exporter to Singapore
- Lenalidomide 10 mg exporter to Canada
- Lenalid 10 mg exporter to South Korea
- Lenalidomide 10 mg exporter to UAE
- Lenalid 10 mg capsules supplier from India
- Lenalidomide capsules wholesale supplier
- Lenalid 10 mg oncology medicine supplier
- Lenalidomide 10 mg oncology pharmaceutical exporter
- Lenalid 10 mg multiple myeloma medicine supplier
- Lenalidomide 10 mg MDS medicine supplier
- Lenalid 10 mg trusted pharma exporter
- Lenalidomide 10 mg verified pharmaceutical supplier
- Lenalid 10 mg bulk medicine supplier India
- Lenalid 10 mg international pharmaceutical distribution
- Lenalidomide 10 mg B2B medicine exporter
- Lenalid 10 mg capsule supplier Nagpur India
- Lenalidomide 10 mg global pharma supply
- Lenalid 10 mg prescription oncology medicine supplier
- Phoenix Exim Lenalid 10 mg pharmaceutical exporter
Keywords







